DK2209798T3 - modified væksthormonpolypeptider - Google Patents

modified væksthormonpolypeptider Download PDF

Info

Publication number
DK2209798T3
DK2209798T3 DK08788565T DK08788565T DK2209798T3 DK 2209798 T3 DK2209798 T3 DK 2209798T3 DK 08788565 T DK08788565 T DK 08788565T DK 08788565 T DK08788565 T DK 08788565T DK 2209798 T3 DK2209798 T3 DK 2209798T3
Authority
DK
Denmark
Prior art keywords
ser
leu
glu
thr
gly
Prior art date
Application number
DK08788565T
Other languages
Danish (da)
English (en)
Inventor
Peter Artymiuk
Richard A Ross
Jon Sayers
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterion Ltd filed Critical Asterion Ltd
Application granted granted Critical
Publication of DK2209798T3 publication Critical patent/DK2209798T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK08788565T 2007-10-10 2008-09-10 modified væksthormonpolypeptider DK2209798T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides
PCT/GB2008/003056 WO2009047474A2 (en) 2007-10-10 2008-09-10 Modified growth hormone polypeptides

Publications (1)

Publication Number Publication Date
DK2209798T3 true DK2209798T3 (en) 2015-03-23

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08788565T DK2209798T3 (en) 2007-10-10 2008-09-10 modified væksthormonpolypeptider

Country Status (17)

Country Link
US (2) US8273552B2 (cg-RX-API-DMAC7.html)
EP (2) EP2886553A1 (cg-RX-API-DMAC7.html)
JP (1) JP5697983B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100067686A (cg-RX-API-DMAC7.html)
CN (1) CN101932600B (cg-RX-API-DMAC7.html)
AR (1) AR068038A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309386A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2701369A1 (cg-RX-API-DMAC7.html)
DK (1) DK2209798T3 (cg-RX-API-DMAC7.html)
ES (1) ES2532600T3 (cg-RX-API-DMAC7.html)
GB (1) GB0719818D0 (cg-RX-API-DMAC7.html)
IL (1) IL203073A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010003892A (cg-RX-API-DMAC7.html)
RU (1) RU2471808C2 (cg-RX-API-DMAC7.html)
TW (1) TW200918098A (cg-RX-API-DMAC7.html)
WO (1) WO2009047474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
CA2447632C (en) * 2000-06-16 2011-08-02 Asterion Limited Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor
ATE509097T1 (de) 2001-11-21 2011-05-15 Us Health Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
WO2004090135A2 (en) 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
MX2007001180A (es) * 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
EP2288386A1 (en) * 2008-02-19 2011-03-02 Asterion Limited Modified linkers

Also Published As

Publication number Publication date
CN101932600A (zh) 2010-12-29
CN101932600B (zh) 2014-05-28
BRPI0818639A2 (pt) 2015-04-07
AR068038A1 (es) 2009-10-28
EP2209798A2 (en) 2010-07-28
WO2009047474A2 (en) 2009-04-16
CA2701369A1 (en) 2009-04-16
US20100197589A1 (en) 2010-08-05
US8273552B2 (en) 2012-09-25
JP5697983B2 (ja) 2015-04-08
IL203073A0 (en) 2010-11-30
WO2009047474A3 (en) 2010-09-02
GB0719818D0 (en) 2007-11-21
JP2011507487A (ja) 2011-03-10
ES2532600T3 (es) 2015-03-30
MX2010003892A (es) 2010-05-17
KR20100067686A (ko) 2010-06-21
TW200918098A (en) 2009-05-01
US20120322735A1 (en) 2012-12-20
EP2209798B1 (en) 2014-12-31
EP2886553A1 (en) 2015-06-24
AU2008309386A1 (en) 2009-04-16
RU2471808C2 (ru) 2013-01-10
RU2010103159A (ru) 2011-11-20

Similar Documents

Publication Publication Date Title
FI117055B (fi) Menetelmä asyloidun insuliinin valmistamiseksi
TWI760333B (zh) Gdf15融合蛋白及其用途
EP0871665B1 (en) Insulin derivatives
EP0728147B1 (en) Receptor specific atrial natriuretic peptides
JP2024010090A (ja) リラキシン融合ポリペプチドおよびその使用
US8470559B2 (en) Growth hormone fusion proteins
CN108570109A (zh) 包含免疫球蛋白Fc部分的双靶点融合蛋白
CA2275183A1 (en) Ob fusion protein compositions and methods
KR100879553B1 (ko) 변형 폴리펩티드
CN114591415B (zh) Glp-1/gcg双受体激动剂多肽及其融合蛋白
JP2014169309A (ja) 59位にアミノ酸置換を有するインスリン様増殖因子−1(igf−1)の類似体
CN110678550A (zh) 长效肾上腺髓质素衍生物
EP2209798B1 (en) Modified growth hormone polypeptides
IL285930B1 (en) Recombinant ccn domain proteins and fusion proteins
WO2011011071A2 (en) Analogues of insulin-like growth factor-1 (igf-1)
US20170015724A1 (en) Growth Hormone Receptor Agonists
EP0454367B1 (en) Growth hormone releasing factor analogs
WO2026082073A1 (zh) 一种嵌合利钠肽或其变体及其应用